Tirofiban for Successful Endovascular Stroke Thrombectomy

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

712

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

October 31, 2026

Conditions
Stroke, Acute Ischemic
Interventions
DRUG

Intraarterial and intravenous tirofiban

Intraarterial and intravenous tirofiban after endovascular thrombectomy

DRUG

Intraarterial and intravenous placebo

Intraarterial and intravenous placebo after endovascular thrombectomy

All Listed Sponsors
collaborator

Mianyang Central Hospital

OTHER

collaborator

The Second Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

The Second Hospital of Jiaozuo

UNKNOWN

collaborator

Chongzhou People's Hospital

UNKNOWN

collaborator

Xihua People's Hospital

UNKNOWN

collaborator

Xingguo People's Hospital

UNKNOWN

lead

Zhongming Qiu

OTHER

NCT06373042 - Tirofiban for Successful Endovascular Stroke Thrombectomy | Biotech Hunter | Biotech Hunter